Pembro ' New Treatment of Choice ' for MSI-H/dMMR Metastatic CRC Pembro ' New Treatment of Choice ' for MSI-H/dMMR Metastatic CRC
David Kerr reports on the most important trial in colorectal cancer at ASCO 2020 from his kitchen, where he ' s ' anchored ' to his chair.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news